The global tissue diagnostics market size was valued at USD 4.2 billion in 2019 and is expected to record a 5% CAGR during the analysis period. Tissue diagnosis is one of the gold standards for cancer diagnosis because these techniques capture the biological context of a tumor. With increasing cancer incidence, the tissue diagnostics market has witnessed high demand along with profitable growth opportunities in the near future.
Tumors can be diagnosed faster as research institutions’ adoption of automated tissue-based diagnostic systems increases. For example, in September 2019, the West Clinic Cancer Center partnered with F. Hoffmann-La Roche Ltd. to improve patient care using Roche’s BenchMark ULTRA automated advanced staining system. This system is used for in situ hybridization or immunohistochemical testing, which allows rapid diagnosis of tumors.
(Get 15% Discount on Buying this Report)
A full report of Tissue Diagnostics Market available at: https://www.orionmarketreports.com/biometric-technology-market/29905/
Tissue Diagnostics Market Segments:
By Disease
• Lung Cancer
• Lymphoma
• Pancreatic
• Cancer
• Breast Cancer
• Others
By Product
• Instruments
• Microscope
• Non-contact Handheld IR Thermometer
• Haemocytometer
• NMR Tube
• Others
• Consumables
• Reagent Kits
• Others
By Application
• In Situ Hybridization
• Hematoxylin and Eosin (H&E)
• Immunohistochemistry (IHC)
By End-User
• Diagnostic Laboratories
• Hospitals
• Contract Research Organizations
• Research Organizations
• Biotechnology Companies
Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
